Overview

ZAGAL Study: Evaluating Effectiveness and Tolerability of Zonisamide as Adjunctive Therapy in Patients With Partial Onset Seizures Treated With Two Antiepileptic Drugs

Status:
Completed

Trial end date:
2009-09-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to acquire additional information about the appropriate level of dosing of Zonisamide when it is prescribed for patients with partial onset epileptic crisis who are already being treated with two other antiepileptic drugs.

Phase:

Phase 4

Details

Lead Sponsor:

Eisai Inc.

Collaborators:

Eisai Farmacêutica S.A.
Eisai Farmaceutica, S.A.

Treatments:

Anticonvulsants
Zonisamide